Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early clinical trial of nebulized prednisolone for adrenal crisis treatment development
NL-OMON51709Completed
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of prednisolone in hypoadrenocorticism, sponsored by University Medical Center Groningen. Primary endpoints: Time to peak serum prednisolone concentration and Prednisolone area under the curve. Started Oct 2022; status: completed.
02
Drugs
prednisolone
03
Conditions
hypoadrenocorticism
Beyond the preview
Go deeper on NL-OMON51709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51709.